Baldwin Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Sell
3,442
-111
-3% -$9.3K 0.02% 186
2026
Q1
$285K Sell
3,553
-800
-18% -$66K 0.02% 187
2025
Q4
$371K Sell
4,353
-720
-14% -$59.1K 0.02% 180
2025
Q3
$395K Sell
5,073
-540
-10% -$42.2K 0.03% 167
2025
Q2
$439K Sell
5,613
-1,035
-16% -$77.2K 0.03% 152
2025
Q1
$482K Sell
6,648
-340
-5% -$24.3K 0.03% 146
2024
Q4
$517K Sell
6,988
-5,300
-43% -$371K 0.04% 145
2024
Q3
$811K Sell
12,288
-14,661
-54% -$1.07M 0.06% 137
2024
Q2
$2.49M Sell
26,949
-708
-3% -$62.7K 0.19% 77
2024
Q1
$2.64M Sell
27,657
-1,909
-6% -$160K 0.2% 78
2023
Q4
$2.25M Sell
29,566
-4,975
-14% -$346K 0.18% 78
2023
Q3
$2.39M Buy
34,541
+3,858
+13% +$310K 0.21% 81
2023
Q2
$2.89M Sell
30,683
-312
-1% -$27.1K 0.24% 79
2023
Q1
$2.56M Buy
30,995
+510
+2% +$40.1K 0.22% 84
2022
Q4
$2.27M Buy
+30,485
New +$2.35M 0.21% 90
2021
Q3
Sell
-10
Closed -$1K 649
2021
Q2
$1K Buy
+10
New +$943 ﹤0.01% 640
2017
Q1
Sell
-24
Closed -$1K 506
2016
Q4
$1K Hold
24
﹤0.01% 500
2016
Q3
$1K Buy
+24
New +$904 ﹤0.01% 520

Other funds holding EW

Baldwin Wealth Partners's EW Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $9.3K and leaving 3,442 shares worth $311K. The position accounts for 0.02% of the portfolio, ranked #186.

Baldwin Wealth Partners first reported a position in EW in Q3 2016 and has held it in 18 quarters since. The position peaked at $2.89M in Q2 2023. 558 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Baldwin Wealth Partners held 3,442 shares of Edwards Lifesciences worth $311K as of Q2 2026.
  • Baldwin Wealth Partners sold 111 Edwards Lifesciences shares in Q2 2026, an estimated $9.3K.
  • Edwards Lifesciences made up 0.02% of Baldwin Wealth Partners's portfolio in Q2 2026, its #186 holding.
  • Baldwin Wealth Partners first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 18 quarters since.
  • Baldwin Wealth Partners's Edwards Lifesciences position peaked at $2.89M in Q2 2023.
  • 558 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.